says Medical Technology Stock Letter, based in Berkeley. The newsletter says companies to be represented at the meeting include Chiron Corp. (ticker symbol: CHIR), ISIS Pharmaceuticals (ISIP), Immunex (IMNX) and Ligand …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND Keywords: Ligand …
A better-ranked stock in the health care sector is Ligand Pharmaceuticals Inc. LGND, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Story Continues Ligand’s earnings per …
It also upped Ligand Pharmaceuticals Inc (NASDAQ:LGND) stake by 3,744 shares and now owns 71,413 shares. …
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the …
Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $155.97 to a high of $160.33. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $156.30 on volume of 203,000 …